Evidence map›Paper›PMID 40611285›Full record

ArticleBMC chemistry2025

Accuracy and feasibility analysis of computational chemistry in drug spectral simulation-a case study of acetylsalicylic acid.

Haitao Cao, Junjian Zeng, Lixin Xue

Abstract read
In one paragraph

Article in BMC chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Haitao CaoDepartment of Cardiovascular Medicine, Wenling First People's Hospital affiliated to Wenzhou Medical University, Wenling, Zhejiang, 317510, China.
Junjian ZengShaoxing University Yuanpei College, Shaoxing, Zhejiang, 312300, China. 745036425@qq.com.
Lixin XueCollege of Chemistry and Materials Engineering, Wenzhou University, Wenzhou, Zhejiang, 325035, China.

Funding

National Ministry of Education Industry-University Cooperation Education Project 230905236265701
6 · The paper itself

Abstract

backgroundTraditional pharmaceutical experiments often involve diverse drug compounds with distinct synthesis and identification requirements, typically relying on substantial amounts of chemical reagents and sophisticated analytical instruments-factors that present notable limitations in teaching environments.

objectivesThis study aims to demonstrate the feasibility and educational value of integrating computational methods into drug synthesis and analysis, using acetylsalicylic acid (ASA) as a case study.

methodsStudents synthesized ASA experimentally and used molecular modeling and spectral simulation tools to analyze the compound. Computational techniques were employed to simulate UV-Vis, infrared (IR), and Raman spectra, with comparisons made to experimental results. The COSMO solvation model was applied to investigate solvent effects, and discrepancies in spectral peak assignments were resolved using computational data.

resultsComparison of experimental and simulated spectra demonstrated high consistency, with R² values of 0.9933 and 0.9995, confirming the predictive power of the computational model. Solvent effects, such as the redshift of UV absorption in aqueous media, were successfully reproduced. Computational analysis resolved ambiguous IR peak assignments caused by overlap or impurities. While limitations such as the lack of NMR data, use of a single functional (GGA/BLYP), and simplified solvation were acknowledged, the integrated approach significantly improved student engagement and conceptual understanding. This study demonstrates the pedagogical and analytical benefits of combining experimental and computational methods, enhancing interpretative accuracy, supporting green chemistry, and offering a reproducible, resource-efficient framework for pharmaceutical education.

Indexed as

Computational chemistryExperimental teachingGreen chemistryMolecular spectroscopyPharmacy

Identifiers

PMID40611285
PMCPMC12225354

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.